J9266 Pegaspargase injection
Also known as: pegaspargase, Oncaspar
Injection of pegaspargase, a pegylated L-asparaginase enzyme. A protein synthesis inhibitor used in acute lymphoblastic leukemia treatment.
In Plain Language
leukemia injection; blood cancer enzyme therapy
Clinical Context
Used in combination chemotherapy for acute lymphoblastic leukemia in pediatric and adult patients. Part of standard induction and consolidation regimens.
RVU Information
CPT J9266 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9266?
CPT J9266 (Pegaspargase injection) is a J Codes (Drugs) code. Injection of pegaspargase, a pegylated L-asparaginase enzyme. A protein synthesis inhibitor used in acute lymphoblastic leukemia treatment.
How is J9266 administered?
CPT J9266 is administered by a healthcare provider, typically via injection or infusion. Used in combination chemotherapy for acute lymphoblastic leukemia in pediatric and adult patients. Part of standard induction and consolidation regimens. It is used by Oncology, Pediatric Hematology, Hematology.
When is CPT J9266 used?
Used in combination chemotherapy for acute lymphoblastic leukemia in pediatric and adult patients. Part of standard induction and consolidation regimens.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.